ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 624851 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 624851; 2) Community: the network communities that were significantly associated with the response to NSC 624851; 3) Molecule: the relationships between components within communities and NSC 624851; 4) MDR: the compounds that were significantly associated with the NSC 624851.

NSC Compound Enrichment Correlation
NSC 658257 Naphthalen-2-one, 4-[(4-bromophenyl)amino]-1,2-dihydro-1-(hydroxyimino)- 0.00337662564965907 -0.092536203
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.00337662564965907 -0.011115334
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.00337662564965909 0.21307987
NSC 132313 Dianhydrogalactitol 0.00337662564965909 0.60968712
NSC 154948 M-AMSA 0.00337662564965909 0.43383791
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.00337662564965909 0.17887622
NSC 300289 Pinafide 0.00337662564965909 0.48314665
NSC 303861 L-Cysteine analog 0.00337662564965909 0.62373843
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.00337662564965909 0.54339565
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00337662564965909 0.40918805
Total:106  Current:15    [First] [Prev] [Next] [Last]